159 related articles for article (PubMed ID: 17342693)
1. [Hyperhomocysteinemia and alternate vitamin supplementation].
De Angelis S; Noce A; Dessì M; Pastore A; Scaccia F; Trombetta M; Tozzo C; Splendiani G
G Ital Nefrol; 2007; 24(1):51-5. PubMed ID: 17342693
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
Azadibakhsh N; Hosseini RS; Atabak S; Nateghiyan N; Golestan B; Rad AH
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
[TBL] [Abstract][Full Text] [Related]
3. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
4. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
[TBL] [Abstract][Full Text] [Related]
5. Oral vitamin B12 supplementation reduces plasma total homocysteine concentration in women in India.
Yajnik CS; Lubree HG; Thuse NV; Ramdas LV; Deshpande SS; Deshpande VU; Deshpande JA; Uradey BS; Ganpule AA; Naik SS; Joshi NP; Farrant H; Refsum H
Asia Pac J Clin Nutr; 2007; 16(1):103-9. PubMed ID: 17215186
[TBL] [Abstract][Full Text] [Related]
6. Effect of multivitamin supplementation on the homocysteine and methylmalonic acid blood concentrations in women over the age of 60 years.
Wolters M; Hermann S; Hahn A
Eur J Nutr; 2005 Mar; 44(3):183-92. PubMed ID: 15309436
[TBL] [Abstract][Full Text] [Related]
7. Hyperhomocysteinemia in children treated with antiepileptic drugs is normalized by folic acid supplementation.
Huemer M; Ausserer B; Graninger G; Hubmann M; Huemer C; Schlachter K; Tscharre A; Ulmer H; Simma B
Epilepsia; 2005 Oct; 46(10):1677-83. PubMed ID: 16190942
[TBL] [Abstract][Full Text] [Related]
8. The effect of long-term intravenous high dose B-complex vitamins with or without folic acid on serum homocysteine in hemodialysis patients.
Sombolos K; Fragia T; Natse T; Bartholomatos G; Karagianni A; Katsaris G; Christidou F; Bamichas G; Stangou M; Papagalanis N
J Nephrol; 2002; 15(6):671-5. PubMed ID: 12495282
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design for the CARDIOVIT Study (Cardiovit, Atherosclerotic vascular disease and hypeRhomocysteinemia: an epiDemiological study in Indians, additionally evaluating the effect of Oral VITamin supplementation).
Shenoy KT; Lena KB; Sali N; Syam S; Shenoy ST; Rajadhyaksha VD; Pai GP; Shaikh AA;
Curr Med Res Opin; 2006 Apr; 22(4):641-8. PubMed ID: 16684424
[TBL] [Abstract][Full Text] [Related]
10. The C677T MTHFR genotypes influence the efficacy of B9 and B12 vitamins supplementation to lowering plasma total homocysteine in hemodialysis.
Achour O; Elmtaoua S; Zellama D; Omezzine A; Moussa A; Rejeb J; Boumaiza I; Bouacida L; Rejeb NB; Achour A; Bouslama A
J Nephrol; 2016 Oct; 29(5):691-8. PubMed ID: 26559681
[TBL] [Abstract][Full Text] [Related]
11. Effects of folic acid fortification and multivitamin therapy on homocysteine and vitamin B(12) status in cardiac transplant recipients.
Miriuka SG; Langman LJ; Keren ES; Miner SE; Mamer OA; Delgado DH; Evrovski J; Ross HJ; Cole DE
J Heart Lung Transplant; 2004 Apr; 23(4):405-12. PubMed ID: 15063399
[TBL] [Abstract][Full Text] [Related]
12. Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
Hyndman ME; Manns BJ; Snyder FF; Bridge PJ; Scott-Douglas NW; Fung E; Parsons HG
Metabolism; 2003 Feb; 52(2):168-72. PubMed ID: 12601627
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J
Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
[TBL] [Abstract][Full Text] [Related]
14. Effects of short-term folic acid and/or riboflavin supplementation on serum folate and plasma total homocysteine concentrations in young Japanese male subjects.
Araki R; Maruyama C; Igarashi S; Yoshida M; Maruyama T; Satoh T; Yoshida M; Umegaki K
Eur J Clin Nutr; 2006 May; 60(5):573-9. PubMed ID: 16391577
[TBL] [Abstract][Full Text] [Related]
15. [Effect of folic acid supplementation on total homocysteine levels in hemodialysis patients].
Armada E; Pérez Melón C; Otero A; Gayoso P; Rodríguez M; Esteban Morcillo J
Nefrologia; 2001; 21(2):167-73. PubMed ID: 11464650
[TBL] [Abstract][Full Text] [Related]
16. Plasma homocysteine after insulin infusion in type II diabetic patients with and without methionine intolerance.
Ventura P; Panini R; Emiliani S; Salvioli G
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):44-51. PubMed ID: 14758571
[TBL] [Abstract][Full Text] [Related]
17. Folic acid administration and antibodies against homocysteinylated proteins in subjects with hyperhomocysteinemia.
Undas A; Stepień E; Glowacki R; Tisończyk J; Tracz W; Jakubowski H
Thromb Haemost; 2006 Sep; 96(3):342-7. PubMed ID: 16953277
[TBL] [Abstract][Full Text] [Related]
18. Effects of folic acid before and after vitamin B12 on plasma homocysteine concentrations in hemodialysis patients with known MTHFR genotypes.
Pastore A; De Angelis S; Casciani S; Ruggia R; Di Giovamberardino G; Noce A; Splendiani G; Cortese C; Federici G; Dessi' M
Clin Chem; 2006 Jan; 52(1):145-8. PubMed ID: 16391331
[TBL] [Abstract][Full Text] [Related]
19. B-group vitamin supplementation mitigates oxidative damage after acute ischaemic stroke.
Ullegaddi R; Powers HJ; Gariballa SE
Clin Sci (Lond); 2004 Nov; 107(5):477-84. PubMed ID: 15279619
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK
J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
